284 related articles for article (PubMed ID: 12110006)
1. Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
Panzer U; Schneider A; Guan Y; Reinking R; Zahner G; Harendza S; Wolf G; Thaiss F; Stahl RA
Kidney Int; 2002 Aug; 62(2):455-64. PubMed ID: 12110006
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
3. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
[TBL] [Abstract][Full Text] [Related]
4. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
7. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
Chen NG; Han X
Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
[TBL] [Abstract][Full Text] [Related]
8. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells.
Haberstroh U; Pocock J; Gómez-Guerrero C; Helmchen U; Hamann A; Gutierrez-Ramos JC; Stahl RA; Thaiss F
Kidney Int; 2002 Oct; 62(4):1264-76. PubMed ID: 12234296
[TBL] [Abstract][Full Text] [Related]
9. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
10. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis.
Panzer U; Thaiss F; Zahner G; Barth P; Reszka M; Reinking RR; Wolf G; Helmchen U; Stahl RA
Kidney Int; 2001 May; 59(5):1762-9. PubMed ID: 11318946
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
14. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
Ruiz-Ortega M; Bustos C; Hernández-Presa MA; Lorenzo O; Plaza JJ; Egido J
J Immunol; 1998 Jul; 161(1):430-9. PubMed ID: 9647253
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
[TBL] [Abstract][Full Text] [Related]
17. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
[TBL] [Abstract][Full Text] [Related]
18. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
[TBL] [Abstract][Full Text] [Related]
19. The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis.
Panzer U; Schneider A; Wilken J; Thompson DA; Kent SB; Stahl RA
Kidney Int; 1999 Dec; 56(6):2107-15. PubMed ID: 10594786
[TBL] [Abstract][Full Text] [Related]
20. Vascular smooth muscle cell activation by C-reactive protein.
Hattori Y; Matsumura M; Kasai K
Cardiovasc Res; 2003 Apr; 58(1):186-95. PubMed ID: 12667961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]